Metrics as of 10/17/2026, 09:26 AM (Berlin time), refresh in progress.
PhenixFIN Corporation
PhenixFIN Corporation functions as a Business Development Company (BDC), concentrating its investment efforts on privately arranged debt and equity instruments issued by small and mid-sized businesses. The firm's primary geographical focus is North America. It targets private debt investments in companies with…
1D
+0.1%
1W
-2.0%
1M
-4.7%
6M
+7.4%
YTD
-0.3%
1Y
-3.2%
2Y
-7.9%
5Y
+2.8%
10Y
-71.2%
Next earnings date
11/12/2026 (in 55 days)
Volatility around earnings
~31% weaker price swings than usual
0
STRONG BUY
0
BUY
1
HOLD
0
SELL
0
STRONG SELL
1
TOTAL · Hold
As of: 23/07/2021
P/E
18.2
P/B
0
EV/EBITDA
-163.02
RETURN ON EQUITY
0.0%
NET MARGIN
61.6%
DEBT/EQUITY
0
DIVIDEND YIELD
0.2%
AS OF
30/06/2026
FREE FLOAT
72.0%
FLOAT SHARES
1,389,647
AVG. DAILY VOLUME (30D)
4,611
Lorber David A
Lorber David A
Lorber David A
Lorber David A
Lorber David A
PhenixFIN Corporation is a company in the Financial Services sector, Asset Management industry, headquartered in United States.
The CEO is David Aaron Lorber, the company employs around 11 people.
The IPO was on 20/01/2011; the stock trades on NASDAQ under the ticker PFX.
1 analysts rate the stock, the consensus is Hold (as of 23/07/2021).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 11/12/2026.
Around past earnings, price swings were roughly -31% stronger than usual.
Yes. The last dividend was US$0.07 per share, ex-date 18/05/2026, paid on 28/05/2026.
The dividend yield is 0.2% (as of 30/06/2026).
Comparable stocks include BlackRock, Blackstone, KKR &, Apollo Global Management, State Street, Ameriprise Financial, Ares Management and Northern Trust.
Clicking "Analyze stock" lets five strategies assess PhenixFIN against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.